Keyphrases
Clinical Efficacy
100%
Cancer Immunotherapy
100%
Natural Killer
100%
Antibody-mediated
100%
Outcome-based
100%
Potential Predictors
100%
Antibody-dependent Cellular Cytotoxicity
100%
Natural Antibodies
100%
Clinical Outcomes
100%
High-risk Neuroblastoma
100%
Neuroblastoma
80%
Monoclonal Antibody
40%
Anti-GD2
40%
Antitumor Activity
20%
Genotype
20%
Chemotherapy
20%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
20%
Granulocyte Colony-stimulating Factor (G-CSF)
20%
Fc Receptor
20%
Ligand-receptor Binding
20%
Antibody Targeting
20%
Fusion Protein
20%
Surgical Resection
20%
Early Phase Clinical Trials
20%
Recurrent Disease
20%
Tumor Therapy
20%
Immune Effector Cells
20%
Predictive Marker
20%
Effector Cells
20%
Preclinical Data
20%
Tumor Subtype
20%
Therapeutic Outcome
20%
Aggressive Treatment
20%
Natural Killer Cell Activity
20%
Neuroblastoma Cells
20%
Multimodality
20%
Disialoganglioside
20%
Cytotoxicity Activity
20%
Genotype Profile
20%
Cis-retinoic Acid
20%
Hu14.18-IL2
20%
Cancer-free Survival
20%
Local Radiation Therapy
20%
Anti-tumor Response
20%
Further Analysis
20%
Affect Responses
20%
Medicine and Dentistry
Ganglioneuroblastoma
100%
Cancer Immunotherapy
100%
Antibody Dependent Cellular Cytotoxicity
83%
Receptor
66%
Clinical Study
50%
Neoplasm
33%
Cytokine
33%
Effector Cell
33%
Monoclonal Antibody
33%
Malignant Neoplasm
16%
Cell Function
16%
Cancer Therapy
16%
Cancer
16%
Recurrent Disease
16%
Autologous Stem Cell Transplantation
16%
Tretinoin
16%
Local Excision
16%
Antineoplastic Activity
16%
Granulocyte Macrophage Colony Stimulating Factor
16%
Neuroblastoma Cell
16%
Fc Receptor
16%
Predictive Marker
16%
Emd 273063
16%
Chimeric Protein
16%
Natural Killer Cell
16%
Radiation Therapy
16%
Neuroscience
Neuroblastoma
100%
Cancer Immunotherapy
100%
Antibody-Dependent Cell-Mediated Cytotoxicity
71%
Receptor
57%
Monoclonal Antibody
28%
Stem Cell
14%
Tretinoin
14%
Granulocyte Macrophage Colony-Stimulating Factor
14%
Fc Receptor
14%
Cell Function
14%
Emd 273063
14%
Chimeric Protein
14%
Natural Killer Cell
14%
Radiation Therapy
14%
Immunology and Microbiology
Antibody-Dependent Cell-Mediated Cytotoxicity
100%
Cancer Immunotherapy
100%
Effector Cell
40%
Monoclonal Antibody
40%
Cytokine
40%
Natural Killer Cell
20%
Cell Function
20%
Antineoplastic Activity
20%
Granulocyte Macrophage Colony-Stimulating Factor
20%
Neuroblastoma Cell
20%
Emd 273063
20%
Fc Receptor
20%
Autologous Stem Cell Transplantation
20%